Detalhe da pesquisa
1.
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
Immunity
; 49(1): 178-193.e7, 2018 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29958801
2.
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.
Blood
; 129(7): 906-916, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057639
3.
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 24(3): 594-599, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061535
4.
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT.
Blood
; 125(23): 3655-63, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25788701
5.
Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice.
Eur J Immunol
; 45(5): 1313-25, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639361
6.
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
Am J Hematol
; 91(5): 453-60, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858124
7.
ClonoCluster: A method for using clonal origin to inform transcriptome clustering.
Cell Genom
; 3(2): 100247, 2023 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819662
8.
Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.
Transplant Cell Ther
; 28(1): 18.e1-18.e10, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597852
9.
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting.
Nat Commun
; 12(1): 4365, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272369
10.
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
J Clin Invest
; 131(7)2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571163
11.
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade.
Cell Syst
; 9(4): 375-382.e4, 2019 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606370
12.
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).
J Clin Invest
; 129(9): 3594-3609, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162144
13.
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
J Clin Invest
; 134(9)2024 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38690741
14.
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma.
Oncoimmunology
; 7(10): e1468956, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288340
15.
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.
PLoS One
; 11(6): e0158156, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27347680
16.
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.
J Clin Oncol
; 33(21): 2392-8, 2015 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056179
17.
Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking.
Oncoimmunology
; 3: e28610, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25097801
18.
Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer.
Cancer Immunol Res
; 2(1): 19-26, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24416732
19.
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma.
Cancer Immunol Res
; 2(11): 1051-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252722
20.
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.
J Clin Invest
; 123(12): 5310-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231351